Cell migration inducing hyaluronan binding protein (CEMIP, KIAAI199) contributes to cell migration, invasiveness, uncontrolled proliferation, dedifferentiation, EMT, dysregulation of cytokine pathways, and is associated with poor outcomes in CRC patients [24,105,106]. The gene discussed is CEMIP; the disease is colorectal carcinoma.